The most prominent theory is that GLP-1 medications may sensitize the cutaneous nerves, which are the nerves responsible for sensations in your skin
Chen H, Peng L, Prez de Nanclares M, et al
Bjrnheden T, Levin M, Evaldsson M, Wiklund O
CPT 99445 Documentation Device type and clinical purpose of monitoring Number of days with valid transmitted readings (minimum 2, maximum 15) Confirmation that data was transmitted from an FDA-cleared device Patient consent for RPM services (documented in the medical record) CPT 99470 Documentation Total clinical staff time spent on treatment management (10 to 19 minutes) Date, duration, and method of at least one real-time interactive communication Description of clinical activities performed (data review, care plan adjustment, patient counseling) Time-stamped notes and platform logs supporting the cumulative time claim How to Implement the New Codes in Your Practice Practices already running RPM programs can integrate the new codes with minimal disruption
Semaglutide is typically administered once a week via subcutaneous injection, meaning its injected under the skin
